相关实验视频

Updated: May 25, 2025

Pre-clinical Evaluation of Tyrosine Kinase Inhibitors for Treatment of Acute Leukemia

Pre-clinical Evaluation of Tyrosine Kinase Inhibitors for Treatment of Acute Leukemia

Published on: September 18, 2013

患有慢性髓性白血病的患者使用尼洛丁尼布治疗的牛皮总回归

Tomáš Horňák¹, Daniela Žáčková², Jiří Mayer¹

¹Department of Internal Medicine Hematology and Oncology, Faculty of Medicine, University Hospital Brno, Masaryk University, Brno, Czech Republic.

Annals of hematology

|February 27, 2025

概括

氨酸激酶抑制剂 (TKIs) 改善了慢性髓性白血病 (CML) 的存活率. 尼罗丁尼是一种TKI,意外导致患者的牛皮完全回归,突出显示了一种新的治疗效果.

科学领域:

在瘤学瘤学.
皮肤病学皮肤病学
药理学药理学是指药理学的学科.

背景情况:

氨酸激酶抑制剂 (TKIs) 已经改变了慢性髓性白血病 (CML) 的治疗方法,显著改善了患者的预期寿命.
长期的TKI治疗可能会导致各种不良反应 (AE),包括皮肤问题.
尼罗丁尼是一种TKI,通常与代谢和皮肤AE有关.

关键词:

不良影响不良影响慢性骨髓性白血病慢性骨髓性白血病尼罗丁尼布 (Nilotinib) 是一种牛皮是一种病.铁氨酸激酶抑制剂铁氨酸激酶抑制剂

更多相关视频

HPLC-based Assay to Monitor Extracellular Nucleotide/Nucleoside Metabolism in Human Chronic Lymphocytic Leukemia Cells

HPLC-based Assay to Monitor Extracellular Nucleotide/Nucleoside Metabolism in Human Chronic Lymphocytic Leukemia Cells

Published on: July 20, 2016

Neutrophil Isolation and Analysis to Determine their Role in Lymphoma Cell Sensitivity to Therapeutic Agents

Neutrophil Isolation and Analysis to Determine their Role in Lymphoma Cell Sensitivity to Therapeutic Agents

Published on: March 25, 2016

相关概念视频

Combination Therapies and Personalized Medicine

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...